Dharmarajan Sriram
#154,711
Most Influential Person Now
Researcher
Dharmarajan Sriram's AcademicInfluence.com Rankings
Dharmarajan Sriramcomputer-science Degrees
Computer Science
#8424
World Rank
#8857
Historical Rank
Computational Linguistics
#1875
World Rank
#1895
Historical Rank
Machine Learning
#3447
World Rank
#3490
Historical Rank
Artificial Intelligence
#3747
World Rank
#3802
Historical Rank
Download Badge
Computer Science
Dharmarajan Sriram's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Dharmarajan Sriram Influential?
(Suggest an Edit or Addition)Dharmarajan Sriram's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl] thiosemicarbazide. (1999) (517)
- Betulinic acid and its derivatives: a review on their biological properties. (2005) (470)
- Synthesis and evaluation of anti-HIV activity of isatin β-thiosemicarbazone derivatives (2005) (277)
- Synthesis and antimicrobial activity of Schiff and Mannich bases of isatin and its derivatives with pyrimidine. (1999) (251)
- Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one. (1999) (225)
- Discovery of antimycobacterial spiro-piperidin-4-ones: an atom economic, stereoselective synthesis, and biological intervention. (2008) (209)
- Design and synthesis of anticonvulsants from a combined phthalimide-GABA-anilide and hydrazone pharmacophore. (2007) (201)
- Design, synthesis, and structure-activity correlations of novel dibenzo[b,d]furan, dibenzo[b,d]thiophene, and N-methylcarbazole clubbed 1,2,3-triazoles as potent inhibitors of Mycobacterium tuberculosis. (2012) (182)
- Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin mannich bases. (2000) (175)
- A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines. (2009) (149)
- Abacavir prodrugs: microwave-assisted synthesis and their evaluation of anti-HIV activities. (2006) (147)
- Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones. (2005) (138)
- A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of novel spiro-pyrrolothiazolyloxindoles and their antitubercular evaluation. (2010) (136)
- Discovery of N-(2,6-dimethylphenyl)-substituted semicarbazones as anticonvulsants: hybrid pharmacophore-based design. (2005) (132)
- Novel three-component domino reactions of ketones, isatin and amino acids: synthesis and discovery of antimycobacterial activity of highly functionalised novel dispiropyrrolidines. (2010) (121)
- An atom efficient, solvent-free, green synthesis and antimycobacterial evaluation of 2-amino-6-methyl-4-aryl-8-[(E)-arylmethylidene]-5,6,7,8-tetrahydro-4H-pyrano[3,2-c]pyridine-3-carbonitriles. (2007) (120)
- Camptothecin and its analogues: a review on their chemotherapeutic potential (2005) (116)
- Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives. (2005) (108)
- A facile 1,3-dipolar cycloaddition of azomethine ylides to 2-arylidene-1,3-indanediones: synthesis of dispiro-oxindolylpyrrolothiazoles and their antimycobacterial evaluation. (2010) (108)
- Design, synthesis, and evaluation of thiol-activated sources of sulfur dioxide (SO₂) as antimycobacterial agents. (2012) (105)
- Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. (2006) (104)
- Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection. (2011) (102)
- Synthesis, Antibacterial, Antifungal and Anti-HIV Evaluation of Schiff and Mannich Bases of Isatin and its Derivatives with Triazole (2000) (101)
- Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase. (2006) (100)
- Antimycobacterial activity of spirooxindolo-pyrrolidine, pyrrolizine and pyrrolothiazole hybrids obtained by a three-component regio- and stereoselective 1,3-dipolar cycloaddition (2011) (97)
- Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines. (2006) (94)
- Discovery of new antitubercular oxazolyl thiosemicarbazones. (2006) (94)
- Synthesis, structure-activity relationship of novel substituted 4H-chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylates as potential anti-mycobacterial and anticancer agents. (2011) (89)
- A highly atom economic, chemo-, regio- and stereoselective synthesis and evaluation of spiro-pyrrolothiazoles as antitubercular agents. (2010) (88)
- Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis. (2011) (88)
- Synthesis and Screening for Anti-HIV Activity of Some N-Mannich Bases of Isatin Derivatives (1999) (79)
- Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs. (2005) (77)
- A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles. (2009) (75)
- A highly atom economic, chemo-, regio- and stereoselective synthesis, and discovery of spiro-pyrido-pyrrolizines and pyrrolidines as antimycobacterial agents (2008) (74)
- 2,4-Dimethoxyphenylsemicarbazones with anticonvulsant activity against three animal models of seizures: synthesis and pharmacological evaluation. (2006) (70)
- An atom economic synthesis and antitubercular evaluation of novel spiro-cyclohexanones. (2009) (70)
- Synthesis, Antibacterial, Antifungal And Anti-HIV Activity Of Schiff And Mannich Bases Of Isatin With N-[6-Chlorobenzothiazol-2-yl] Thiosemicarbazide (1999) (65)
- Synthesis, Antibacterial, Antifungal, and Anti-HIV Evaluation of Norfloxacin Mannich Bases. (2010) (64)
- Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives. (2015) (62)
- Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity. (2010) (61)
- Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea. (2006) (61)
- Isonicotinic acid hydrazide derivatives: synthesis, antimicrobial activity, and QSAR studies (2012) (60)
- A facile four-component sequential protocol in the expedient synthesis of novel 2-aryl-5-methyl-2,3-dihydro-1H-3-pyrazolones in water and their antitubercular evaluation. (2011) (58)
- Synthesis and antitubercular evaluation of novel dibenzo[b,d]furan and 9-methyl-9H-carbazole derived hexahydro-2H-pyrano[3,2-c]quinolines via Povarov reaction. (2011) (58)
- Design, synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties. (2004) (57)
- Anticonvulsant and neurotoxicity evaluation of some 6-chlorobenzothiazolyl-2-thiosemicarbazones. (2002) (57)
- Synthesis, antimycobacterial, antiviral, antimicrobial activities, and QSAR studies of nicotinic acid benzylidene hydrazide derivatives (2012) (57)
- Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids. (2009) (57)
- Synthesis of pyrazinamide Mannich bases and its antitubercular properties. (2006) (56)
- The GABA shunt: an attractive and potential therapeutic target in the treatment of epileptic disorders. (2005) (55)
- Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors. (2013) (54)
- Synthesis, Antiviral and Antibacterial Activities of Isatin Mannich Bases (2005) (54)
- Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis. (2007) (54)
- Antimycobacterial activity of novel 1,2,4-oxadiazole-pyranopyridine/chromene hybrids generated by chemoselective 1,3-dipolar cycloadditions of nitrile oxides. (2011) (54)
- Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation. (2008) (52)
- A facile domino protocol for the regioselective synthesis and discovery of novel 2-amino-5-arylthieno-[2,3-b]thiophenes as antimycobacterial agents (2009) (51)
- Antituberculous Activity of Norfloxacin Mannich Bases with Isatin Derivatives (2001) (50)
- Synthesis and antimicrobial activities of some novel substituted 2-imidazolyl-N-(4-oxo-quinazolin-3(4H)-yl)-acetamides. (2007) (49)
- Facile three-component domino reactions in the regioselective synthesis and antimycobacterial evaluation of novel indolizines and pyrrolo[2,1-a]isoquinolines (2010) (49)
- One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity. (2015) (49)
- Synthesis and anticonvulsant and neurotoxicity evaluation of N4-phthalimido phenyl (thio) semicarbazides. (2003) (48)
- Multiple e‐Pharmacophore Modeling Combined with High‐Throughput Virtual Screening and Docking to Identify Potential Inhibitors of β‐Secretase(BACE1) (2013) (47)
- 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species. (2009) (47)
- Inhibition of protein kinase R protects against palmitic acid–induced inflammation, oxidative stress, and apoptosis through the JNK/NF‐kB/NLRP3 pathway in cultured H9C2 cardiomyocytes (2018) (47)
- A microwave-assisted, facile, regioselective Friedländer synthesis and antitubercular evaluation of 2,9-diaryl-2,3-dihydrothieno-[3,2-b]quinolines. (2010) (47)
- Progress in the research of artemisinin and its analogues as antimalarials: an update (2004) (47)
- Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid. (2008) (46)
- 3-Chloro-2-methylphenyl-substituted semicarbazones: synthesis and anticonvulsant activity. (2004) (46)
- Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis. (2014) (46)
- Cyclization of the semicarbazone template of aryl semicarbazones: synthesis and anticonvulsant activity of 4,5-diphenyl-2H-1,2,4-triazol-3(4H)-one. (2009) (45)
- Facile diversity-oriented synthesis and antitubercular evaluation of novel aryl and heteroaryl tethered pyridines and dihydro-6H-quinolin-5-ones derived via variants of the Bohlmann-Rahtz Reaction. (2011) (45)
- A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture (2015) (45)
- A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity. (2011) (44)
- Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents. (2013) (44)
- Anti-HIV Activity Of Some Mannich Bases Of Isatin Derivatives (1998) (44)
- Structure-guided design of novel thiazolidine inhibitors of O-acetyl serine sulfhydrylase from Mycobacterium tuberculosis. (2013) (43)
- Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis. (2014) (43)
- Antituberculous activity of some aryl semicarbazone derivatives. (2004) (42)
- Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies. (2011) (42)
- Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors. (2015) (41)
- Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazones. (2005) (41)
- An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition. (2014) (41)
- Synthesis and in-vitro cytotoxicity evaluation of gatifloxacin Mannich bases. (2005) (41)
- Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids. (2014) (40)
- A Review on GABA/Glutamate Pathway for Therapeutic Intervention of ASD and ADHD (2015) (39)
- Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis. (2016) (38)
- Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. (2016) (38)
- Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents. (2016) (38)
- Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase. (2007) (37)
- Synthesis and antitubercular activities of substituted benzoic acid N'-(substituted benzylidene/furan-2-ylmethylene)-N-(pyridine-3-carbonyl)-hydrazides. (2010) (37)
- 4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation. (2015) (37)
- Synthesis, antimycobacterial, antiviral, antimicrobial activities, and QSAR studies of isonicotinic acid-1-(substituted phenyl)-ethylidene/cycloheptylidene hydrazides (2012) (36)
- Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies. (2016) (36)
- Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations (2018) (35)
- 1,3-Dipolar cycloaddition of C-aryl-N-phenylnitrones to (R)-1-(1-phenylethyl)-3-[(E)-arylmethylidene]tetrahydro-4(1H)-pyridinones: synthesis and antimycobacterial evaluation of enantiomerically pure spiroisoxazolidines. (2010) (35)
- Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads. (2016) (34)
- Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS: design, synthesis and biological evaluation. (2005) (34)
- Synthesis of aryl semicarbazones as potential anticonvulsant agents. (2008) (34)
- Synthesis and antitubercular evaluation of novel substituted aryl and thiophenyl tethered dihydro-6H-quinolin-5-ones. (2011) (34)
- New indole-isoxazolone derivatives: Synthesis, characterisation and in vitro SIRT1 inhibition studies. (2015) (34)
- Synthesis, Antitubercular and Anticancer Activities of Substituted Furyl‐quinazolin‐3(4H)‐ones (2007) (34)
- Synthesis of new spirooxindole derivatives through 1,3-dipolar cycloaddition of azomethine ylides and their antitubercular activity (2016) (34)
- Ion channels as important targets for antiepileptic drug design. (2004) (34)
- N-Arylalkylbenzo[d]thiazole-2-carboxamides as anti-mycobacterial agents: design, new methods of synthesis and biological evaluation (2014) (33)
- Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid. (2007) (33)
- Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening. (2014) (33)
- Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship. (2018) (33)
- Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review (2012) (32)
- An update on GABA analogs for CNS drug discovery. (2006) (32)
- Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis. (2015) (32)
- Synthesis and in vitro antitubercular activity of 4-aryl/alkylsulfonylmethylcoumarins as inhibitors of Mycobacterium tuberculosis. (2012) (32)
- Ultrasonication-ionic liquid synergy for the synthesis of new potent anti-tuberculosis 1,2,4-triazol-1-yl-pyrazole based spirooxindolopyrrolizidines. (2019) (31)
- Towards the design and development of agents with broad spectrum chemotherapeutic properties for the effective treatment of HIV / AIDS. (2003) (31)
- A solvent free, four-component synthesis and 1,3-dipolar cycloaddition of 4(H)-pyrans with nitrile oxides: synthesis and discovery of antimycobacterial activity of enantiomerically pure 1,2,4-oxadiazoles. (2012) (31)
- Synthesis, antimycobacterial, antiviral, antimicrobial activity and QSAR studies of N(2)-acyl isonicotinic acid hydrazide derivatives. (2012) (31)
- Synthesis, antitubercular evaluation and molecular docking studies of phthalimide bearing 1,2,3-triazoles (2019) (31)
- Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents. (2015) (31)
- 4-sulphamoylphenyl semicarbazones with anticonvulsant activity. (2004) (31)
- Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents. (2019) (31)
- 5-Nitro-2-furoic acid hydrazones: design, synthesis and in vitro antimycobacterial evaluation against log and starved phase cultures. (2010) (31)
- Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: scaffold hopping from known antibacterial leads. (2014) (31)
- Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues. (2011) (31)
- Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors. (2015) (30)
- Click-based synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages. (2016) (30)
- Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors. (2016) (30)
- Efavirenz Mannich bases: Synthesis, anti-HIV and antitubercular activities (2009) (29)
- Design, synthesis and evaluation of small molecule reactive oxygen species generators as selective Mycobacterium tuberculosis inhibitors. (2012) (29)
- New class of antitubercular compounds: synthesis and anti-tubercular activity of 4-substituted pyrrolo[2,3-c]quinolines (2014) (29)
- Synthesis of stavudine amino acid ester prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. (2004) (29)
- Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads. (2014) (29)
- 3-D structural interactions and quantitative structural toxicity studies of tyrosine derivatives intended for safe potent inflammation treatment (2016) (29)
- Novel acridinedione derivatives: design, synthesis, SIRT1 enzyme and tumor cell growth inhibition studies. (2012) (29)
- Aminopyrimidinimino isatin analogues: design of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties. (2005) (28)
- Design, Synthesis, and Molecular Docking Studies of a Conjugated Thiadiazole-Thiourea Scaffold as Antituberculosis Agents. (2016) (28)
- Synthesis of novel dispiropyrrolothiazoles by three-component 1,3-dipolar cycloaddition and evaluation of their antimycobacterial activity (2014) (27)
- Antimycobacterial activities of novel fluoroquinolones. (2009) (27)
- Rational design, synthesis and evaluation of novel-substituted 1,2,3-triazolylmethyl carbazoles as potent inhibitors of Mycobacterium tuberculosis (2015) (27)
- Synthesis of highly potent novel anti-tubercular isoniazid analogues with preliminary pharmacokinetic evaluation. (2012) (27)
- Discovery of 4-aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: a hybrid pharmacophore approach. (2007) (27)
- Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads (2019) (26)
- Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis. (2019) (26)
- Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives. (2017) (26)
- Syntheses and biological evaluation of new triazole-spirochromone conjugates as inhibitors of Mycobacterium tuberculosis (2011) (26)
- Synthesis and antitubercular activity of amino alcohol fused spirochromone conjugates. (2013) (26)
- Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors. (2013) (26)
- Identification and structure–activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors (2014) (25)
- Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen (2015) (25)
- Discovery of novel inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (CysK1) using virtual high-throughput screening. (2013) (25)
- Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues. (2014) (25)
- Design, Synthesis and Molecular Docking Studies of Novel Triazole‐Chromene Conjugates as Antitubercular, Antioxidant and Antifungal Agents (2018) (25)
- Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis. (2014) (25)
- Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents. (2019) (25)
- Discovery of novel antitubercular 2,10-dihydro-4aH-chromeno[3,2-c]pyridin-3-yl derivatives. (2010) (25)
- N-Hydroxythiosemicarbazones: synthesis and in vitro antitubercular activity. (2007) (25)
- Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids. (2008) (25)
- Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity. (2019) (24)
- 2-Butyl-4-chloroimidazole based substituted piperazine-thiosemicarbazone hybrids as potent inhibitors of Mycobacterium tuberculosis. (2014) (24)
- Spirochromone-chalcone conjugates as antitubercular agents: synthesis, bio evaluation and molecular modeling studies (2015) (24)
- Synthesis, characterization and biological evaluation of bile acid-aromatic/heteroaromatic amides linked via amino acids as anti-cancer agents (2016) (24)
- 1,3-Dipolar cycloaddition of nitrile oxides to (R)-1-(1-phenylethyl)-3,5-bis[(E)-arylmethylidene]tetrahydro-4(1H)-pyridinones: synthesis and antimycobacterial evaluation of novel enantiomerically pure di- and trispiroheterocycles (2010) (24)
- Layer-by-Layer Thin Films for Co-Delivery of TGF-β siRNA and Epidermal Growth Factor to Improve Excisional Wound Healing (2017) (24)
- Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors. (2015) (24)
- Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors. (2015) (24)
- Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors. (2016) (23)
- Targeting multiple response regulators of Mycobacterium tuberculosis augments the host immune response to infection (2016) (23)
- Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies. (2020) (23)
- Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives. (2014) (23)
- 1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation (2018) (23)
- Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition. (2013) (23)
- Synthesis and antimycobacterial activity of prodrugs of sulfur dioxide (SO2). (2012) (23)
- Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors. (2018) (23)
- A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity. (2017) (23)
- A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis. (2016) (22)
- Discovery of molecules for the treatment of neuropathic pain: synthesis, antiallodynic and antihyperalgesic activities of 5-(4-nitrophenyl)furoic-2-acid hydrazones. (2011) (22)
- Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents. (2015) (22)
- Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1) (2016) (22)
- Potential role of Rho kinase inhibitors in combating diabetes-related complications including diabetic neuropathy--a review. (2013) (22)
- Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling. (2015) (22)
- Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis. (2009) (22)
- Synthesis, anti-HIV and antitubercular activities of isatin derivatives. (2006) (22)
- Synthesis and in vitro Antitubercular Activity of Some 1-[(4-Sub)phenyl]-3-(4-{1- [(pyridine-4-carbonyl)-hydrazono]ethyl}phenyl)thiourea. (2006) (22)
- L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines. (2009) (22)
- Pyridoxal-phosphate dependent mycobacterial cysteine synthases: Structure, mechanism and potential as drug targets. (2015) (22)
- Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors. (2014) (21)
- Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors. (2017) (21)
- Synthesis and evaluation of anti-HIV activity of isatin beta-thiosemicarbazone derivatives. (2005) (21)
- Neuropathic pain: strategies in drug discovery and treatment (2007) (21)
- Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics. (2015) (21)
- Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain. (2015) (21)
- Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: hit to lead optimization of a novel class of thiazole inhibitors. (2015) (21)
- Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor. (2011) (21)
- Synthesis, molecular docking, antimycobacterial and antimicrobial evaluation of new pyrrolo[3,2-c]pyridine Mannich bases. (2017) (21)
- Synthesis and antimycobacterial activities of some new N-acylhydrazone and thiosemicarbazide derivatives of 6-methyl-4,5-dihydropyridazin-3(2H)-one (2012) (21)
- Synthesis and Antimycobacterial Evaluation of Novel Phthalazin‐4‐ylacetamides Against log‐ and Starved Phase Cultures (2010) (21)
- Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents. (2019) (20)
- Novel isoniazid embedded triazole derivatives: synthesis, antitubercular and antimicrobial activity evaluation. (2020) (20)
- A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies. (2011) (20)
- The Small Molecule Indirubin-3'-Oxime Inhibits Protein Kinase R: Antiapoptotic and Antioxidant Effect in Rat Cardiac Myocytes (2015) (20)
- Synthesis and antitubercular evaluation of amidoalkyl dibenzofuranols and 1H-benzo[2,3]benzofuro[4,5-e][1,3]oxazin-3(2H)-ones. (2011) (20)
- Structure‐Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors (2014) (20)
- New N-phenylacetamide-incorporated 1,2,3-triazoles: [Et3NH][OAc]-mediated efficient synthesis and biological evaluation (2019) (20)
- Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents. (2020) (20)
- Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives. (2015) (19)
- Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors. (2020) (19)
- Dibenzofuran, dibenzothiophene and N-methyl carbazole tethered 2-aminothiazoles and their cinnamamides as potent inhibitors of Mycobacterium tuberculosis. (2018) (19)
- Future directions in the treatment of neuropathic pain: a review on various therapeutic targets. (2014) (19)
- Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis. (2019) (19)
- Camphorsulfonic acid catalysed facile tandem double Friedlander annulation protocol for the synthesis of phenoxy linked bisquinoline derivatives and discovery of antitubercular agents. (2012) (19)
- Nicotinic Acid Benzylidene/Phenyl-Ethylidene Hydrazides: Synthesis, Antimicrobial Evaluation and QSAR Studies (2011) (19)
- Synthesis and anti-HIV activity of N'-nicotinoyl--3-(4'-hydroxy-3'-methylphenyl)-5-[substituted phenyl]-2-pyrazolines. (2007) (19)
- Novel Zebrafish EAE model: A quick in vivo screen for multiple sclerosis. (2017) (19)
- Synthesis of new pyrazole-triazole hybrids by click reaction using a green solvent and evaluation of their antitubercular and antibacterial activity (2016) (19)
- Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis. (2019) (18)
- Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis. (2019) (18)
- Synthesis and in vitro Antimycobacterial Activity of N1-Nicotinoyl-3-(4′-hydroxy-3′-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines. (2006) (18)
- Efavirenz Mannich bases: synthesis, anti-HIV and antitubercular activities. (2009) (18)
- Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors. (2020) (18)
- Synthesis of N4-(2,4-dimethylphenyl) semicarbazones as 4-aminobutyrate aminotransferase inhibitors. (2006) (18)
- α-Sulfonamidophosphonates as new anti-mycobacterial chemotypes: Design, development of synthetic methodology, and biological evaluation. (2019) (18)
- Three-component, one-pot synthesis of anthranilamide Schiff bases bearing 4-aminoquinoline moiety as Mycobacterium tuberculosis gyrase inhibitors. (2017) (18)
- Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides. (2016) (17)
- Sugar-boronate ester scaffold tethered pyridyl-imine palladium(II) complexes: synthesis and their in vitro anticancer evaluation. (2015) (17)
- Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers (2016) (17)
- Anti HIV And Antibacterial Activities Of Some Disubstitutedquinazolones And Their Bio-Isostere Disubstitutedthienopyrimidones (2000) (17)
- Antimycobacterial and phototoxic evaluation of novel 6-fluoro/nitro-4-oxo-7-(sub)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid. (2008) (17)
- Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents. (2020) (17)
- Synthesis and screening of (E)-1-(β-D-galactopyranosyl)-4-(aryl)but-3-ene-2-one against Mycobacterium tuberculosis. (2011) (17)
- Optimization and validation of Mycobacterium marinum-induced adult zebrafish model for evaluation of oral anti-tuberculosis drugs. (2014) (17)
- Design of dual inhibitors of ROCK-I and NOX2 as potential leads for the treatment of neuroinflammation associated with various neurological diseases including autism spectrum disorder. (2015) (17)
- Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation. (2020) (17)
- High glucose impairs insulin signaling via activation of PKR pathway in L6 muscle cells. (2017) (16)
- Amsacrine Derivatives Selectively Inhibit Mycobacterial Topoisomerase I (TopA), Impair M. smegmatis Growth and Disturb Chromosome Replication (2018) (16)
- Structure-based drug design of small molecule SIRT1 modulators to treat cancer and metabolic disorders. (2014) (16)
- Evaluation of antimycobacterial and DNA gyrase inhibition of fluoroquinolone derivatives. (2006) (16)
- Imidazo[2,1-b]thiazole-Coupled Natural Noscapine Derivatives as Anticancer Agents (2019) (15)
- Discovery of Novel Mycobacterial DNA Gyrase B Inhibitors: In Silico and In Vitro Biological Evaluation (2014) (15)
- 1,3-Disubstituted urea derivatives: Synthesis, antimicrobial activity evaluation and in silico studies. (2020) (15)
- Anticonvulsant and neurotoxicity evaluation of 5-(un)-substituted isatinimino derivatives. (2001) (15)
- Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus. (2014) (15)
- Identification of potent chromone embedded [1,2,3]-triazoles as novel anti-tubercular agents (2018) (15)
- Discovery and Structure Optimization of a Series of Isatin Derivatives as Mycobacterium tuberculosis Chorismate Mutase Inhibitors (2014) (15)
- Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. (2014) (15)
- Design, synthesis, molecular-docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenones. (2017) (14)
- Anti-tubercular activity of novel class of spiropyrrolidine tethered indenoquinoxaline heterocyclic hybrids. (2020) (14)
- Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase. (2015) (14)
- Synthesis of novel aryl semicarbazones as anticonvulsants with Gaba-mediated mechanism (2003) (14)
- Synthesis, antimycobacterial activities and phototoxic evaluation of 5H-thiazolo[3,2-a]quinoline-4-carboxylic acid derivatives. (2008) (14)
- Synthesis and anticonvulsant activity of 4-(2-(2,6-dimethylphenylamino)-2-oxoethylamino)-N-(substituted)butanamides: a pharmacophoric hybrid approach. (2007) (13)
- Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain (2009) (13)
- Antinociceptive properties of the aqueous and methanol extracts of the stem bark of Petersianthus macrocarpus (P. Beauv.) Liben (Lecythidaceae) in mice. (2015) (13)
- Epibatidine and its analogues as nicotinic acetylcholine receptor agonist: an update (2006) (13)
- Synthesis, Antibacterial And Antifungal Activities Of N-Mannich Bases Of 3-(N2- Pyrimethaminylimino) Isatin (2002) (13)
- Gyrase ATPase Domain as an Antitubercular Drug Discovery Platform: Structure‐Based Design and Lead Optimization of Nitrothiazolyl Carboxamide Analogues (2014) (13)
- Synthesis of carbohydrazides and carboxamides as anti-tubercular agents. (2018) (13)
- Synthesis and evaluation of 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis. (2017) (13)
- Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis. (2015) (13)
- Inhibition of tyrosinase by 4H‐chromene analogs: Synthesis, kinetic studies, and computational analysis (2017) (13)
- Clickable conjugates of bile acids and nucleosides: Synthesis, characterization, in vitro anticancer and antituberculosis studies (2018) (13)
- Polymer–gold nanoparticle composite films for topical application: Evaluation of physical properties and antibacterial activity (2017) (13)
- Synthesis and anti-mycobacterial activity of 2-chloronicotinaldehydes based novel 1H-1,2,3-triazolylbenzohydrazides. (2015) (13)
- Synthesis and screening of galactose-linked nitroimidazoles and triazoles against Mycobacterium tuberculosis. (2011) (13)
- Novel phthalazinyl derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis isocitrate lyase enzyme. (2009) (13)
- Profiling of in vitro activities of urea-based inhibitors against cysteine synthases from Mycobacterium tuberculosis. (2017) (12)
- Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. (2005) (12)
- Newer GABA derivatives for the treatment of epilepsy including febrile seizures: a bioisosteric approach. (2008) (12)
- Synthesis and structure-activity relationship on anticonvulsant aryl semicarbazones. (2006) (12)
- Synthesis of novel 5-[(1,2,3-triazol-4-yl)methyl]-1-methyl-3H-pyridazino[4,5-b]indol-4-one derivatives by click reaction and exploration of their anticancer activity (2015) (12)
- Identification of potential Mycobacterium tuberculosis topoisomerase I inhibitors: a study against active, dormant and resistant tuberculosis. (2015) (12)
- Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis. (2012) (12)
- Ionic liquid-promoted one-pot synthesis of thiazole–imidazo[2,1-b][1,3,4]thiadiazole hybrids and their antitubercular activity (2016) (12)
- Click-based synthesis and antitubercular evaluation of dibenzofuran tethered thiazolyl-1,2,3-triazolyl acetamides. (2016) (12)
- Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity (2015) (12)
- Selective one-pot multicomponent synthesis and anti-tubercular evaluation of 5-(aryl/cyclohexylsulfanyl)-2-alkoxy-4,6-diarylnicotinonitriles. (2010) (12)
- Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead. (2014) (11)
- Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents. (2019) (11)
- Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents. (2020) (11)
- Aminopyrimidinimino isatin analogues: design and synthesis of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum anti-microbial properties. (2005) (11)
- Design and Biological Evaluation of Furan/Pyrrole/Thiophene‐2‐carboxamide Derivatives as Efficient DNA GyraseB Inhibitors of Staphylococcus aureus (2015) (11)
- Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis. (2009) (11)
- Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug (2017) (11)
- Stereoselective synthesis and discovery of novel spirooxindolopyrrolidine engrafted indandione heterocyclic hybrids as antimycobacterial agents. (2021) (11)
- Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis (2021) (11)
- Synthesis, bioevaluation and molecular docking study of new piperazine and amide linked dimeric 1,2,3-triazoles (2019) (11)
- Discovery of Rimonabant and its potential analogues as anti-TB drug candidates (2015) (11)
- Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities (2015) (11)
- Design and Synthesis of Purine Connected Piperazine Derivatives as Novel Inhibitors of Mycobacterium tuberculosis. (2020) (11)
- 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies (2010) (11)
- Discovery of Fused Triazolo-thiadiazoles as Inhibitors of TNF-alpha: Pharmacophore Hybridization for Treatment of Neuropathic Pain (2012) (10)
- Design and Synthesis of New Aryloxy‐linked Dimeric 1,2,3‐TriazolesviaClick Chemistry Approach: Biological Evaluation and Molecular Docking Study (2019) (10)
- Synthesis and biological evaluation of sugar-derived chiral nitroimidazoles as potential antimycobacterial agents. (2011) (10)
- Sacubitril‐Based Urea and Thiourea Derivatives as Novel Inhibitors for Anti‐Tubercular against Dormant Tuberculosis (2021) (10)
- Synthesis, antimicrobial and antimycobacterial evaluation of [2-(substituted phenyl)-imidazol-1-yl]-pyridin-3-yl-methanones (2011) (10)
- Design and development of new class of Mycobacterium tuberculosisl-alanine dehydrogenase inhibitors. (2016) (10)
- Synthesis and antimycobacterial screening of new N-(4-(5-aryl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl)phenyl)-4-amide derivatives (2016) (10)
- Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues. (2014) (10)
- Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA. (2014) (10)
- In silico design of small peptides antagonist against leptin receptor for the treatment of obesity and its associated immune-mediated diseases. (2018) (10)
- Lead identification and optimization of bacterial glutamate racemase inhibitors. (2018) (10)
- Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents. (2018) (10)
- Targeting NAMPT for Therapeutic Intervention in Cancer and Inflammation: Structure‐Based Drug Design and Biological Screening (2015) (10)
- Synthesis and in‐vitro Antimycobacterial Evaluation of 1‐(Cyclopropyl/2,4‐difluorophenyl/tert‐butyl)‐1,4‐dihydro‐ 8‐methyl‐6‐nitro‐4‐oxo‐7‐(substituted secondary amino)quinoline‐3‐carboxylic acids (2009) (10)
- Structure‐Guided Discovery of Antitubercular Agents That Target the Gyrase ATPase Domain (2016) (10)
- Regio- and diastereoselective synthesis of spiropyrroloquinoxaline grafted indole heterocyclic hybrids and evaluation of their anti-Mycobacterium tuberculosis activity (2020) (9)
- Aromatic amino analogues of artemisinin: synthesis and in vivo antimalarial activity (2010) (9)
- "Upregulation of PKR Pathway Mediates Glucolipotoxicity Induced Diabetic Cardiomyopathy In vivo in Wistar Rats and In vitro in Cultured Cardiomyocytes". (2020) (9)
- Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors. (2020) (9)
- A Facile Synthesis and Antituberculosis Properties of Almazole D and Its Enantiomer (2017) (9)
- Synthesis, crystal structure and antimycobacterial activities of 4-indolyl-1,4-dihydropyridine derivatives possessing various ester groups (2017) (9)
- Microwave-assisted synthesis and anti-YFV activity of 2,3-diaryl-1,3-thiazolidin-4-ones. (2005) (8)
- Synthesis and Evaluation of Thiazolyl-1H-benzo[ d ]imidazole Inhibitors of Mycobacterium tuberculosis Inosine Monophosphate Dehydrogenase (2015) (8)
- Newer N-Phthaloyl GABA Derivatives with Antiallodynic and Antihyperalgesic Activities in Both Sciatic Nerve and Spinal Nerve Ligation Models of Neuropathic Pain (2007) (8)
- A Quinoline Compound Inhibits the Replication of Dengue virus Serotypes 1–4 in Vero Cells (2018) (8)
- Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis. (2016) (8)
- Extending the N-linked aminopiperidine class to the mycobacterial gyrase domain: pharmacophore mapping from known antibacterial leads. (2014) (8)
- Investigating structure-activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione [CD59]. (2014) (8)
- Synthesis of Tetrahydro-2H-[1,3,5]thiadiazine-5-(4-pyridylcarboxamido)-2-thione with antitubercular activity (2004) (8)
- General and efficient synthesis of benzoxazol-2(3H)-ones: evolution of their anti-cancer and anti-mycobacterial activities (2014) (8)
- Microwave-assisted synthesis, anticonvulsant activity and quantum mechanical modelling of N-(4-bromo-3-methylphenyl) semicarbazones (2007) (8)
- Salicylanilide Diethyl Phosphates as Potential Inhibitors of Some Mycobacterial Enzymes (2014) (8)
- Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents. (2018) (8)
- Synthesis and antimicrobial evaluation of new nitric oxide‐donating fluoroquinolone/oxime hybrids (2020) (8)
- Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation (2017) (7)
- New fluoroquinolones/nitric oxide donor hybrids: design, synthesis and antitubercular activity (2019) (7)
- Discovery of tetrahydropyrido[4,3-d]pyrimidine derivatives for the treatment of neuropathic pain. (2014) (7)
- Computational Sampling and Simulation Based Assessment of Novel Mycobacterium tuberculosis Glutamine Synthetase Inhibitors: Study Involving Structure Based Drug Design and Free Energy Perturbation. (2015) (7)
- Synthesis, anti‐HIV and Antitubercular Activities of Lamivudine Prodrugs. (2006) (7)
- Discovery of Novel 1,2,4‐Triazol‐5‐Ones as Tumor Necrosis Factor‐Alpha Inhibitors for the Treatment of Neuropathic Pain (2012) (7)
- Pharmacophore-based 3DQSAR and molecular docking studies to identify new non-peptidic inhibitors of cathepsin S. (2014) (7)
- Synthesis And Antibacterial Activity Of Mannich Bases Of Ciprofloxacin And Lomefloxacin With Isatin And Its Derivative (1998) (7)
- Synthesis and bioevaluation of α,α’-bis(1H-1,2,3-triazol-5-ylmethylene) ketones (2019) (7)
- Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents. (2019) (7)
- Isonicotinic Acid Hydrazide Derivatives: Synthesis, Antimycobacterial, Antiviral, Antimicrobial Activity and QSAR Studies (2011) (7)
- Anti-mycobacterial, cytotoxic activities of Knoevenagel and (E)-α,β-unsaturated esters and ketones from 2-chloronicotinaldehydes (2013) (7)
- A Regio‐ and Stereoselective 1,3‐Dipolar Cycloaddition for the Synthesis of Novel Spiro‐Pyrrolothiazolyloxindoles and Their Antitubercular Evaluation. (2011) (7)
- Correlation of pharmacokinetics and brain penetration data of adult zebrafish with higher mammals including humans. (2017) (7)
- Study of Pharmacokinetics and Tissue Distribution of BITS-17 in RatPlasma and Tissue Homogenate Using a Validated LC Method (2012) (7)
- Replacement of cardiotoxic aminopiperidine linker with piperazine moiety reduces cardiotoxicity? Mycobacterium tuberculosis novel bacterial topoisomerase inhibitors. (2016) (6)
- Rational design of coumarin derivatives as antituberculosis agents. (2018) (6)
- Synthesis, in vitro, and in vivo (Zebra fish) antitubercular activity of 7,8-dihydroquinolin-5(6H)-ylidenehydrazinecarbothioamides. (2020) (6)
- Synthesis, anti-HIV and antitubercular activities of nelfinavir diester derivatives. (2008) (6)
- The design and green synthesis of novel benzotriazoloquinolinyl spirooxindolopyrrolizidines: antimycobacterial and antiproliferative studies (2019) (6)
- Discovery of novel tetrahydro-pyrazolo [4,3-c] pyridines for the treatment of neuropathic pain: synthesis and neuropharmacology. (2013) (6)
- Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2‐b]pyridine‐1,3,4‐oxadiazole derivatives (2017) (6)
- An Atom Efficient, Solvent-Free, Green Synthesis and Antimycobacterial Evaluation of 2-Amino-6-methyl-4-aryl-8- [(E)-arylmethylidene]-5,6,7,8-tetrahydro-4H-pyrano [3,2-c]pyridine-3-carbonitriles. (2008) (6)
- Design, Synthesis, and in vitro antitubercular activity of 1,2,3‐triazolyl‐dihydroquinoline derivatives (2018) (6)
- Design, synthesis and biological evaluation of novel Pseudomonas aeruginosa DNA gyrase B inhibitors. (2020) (6)
- Synthesis of Zidovudine Derivatives with Anti-HIV-1 and Antibacterial Activities (2009) (6)
- Synthesis of isoniazid‐1,2,3‐triazole conjugates: Antitubercular, antimicrobial evaluation and molecular docking study (2020) (6)
- Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation (2020) (5)
- 5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation. (2019) (5)
- 5-Methyl-4-thiazolidinones: Synthesis and evaluation as antitubercular agents (2020) (5)
- Canagliflozin and Dapagliflozin Attenuate Glucolipotoxicity-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Inhibition of Sodium-Glucose Cotransporter-1. (2022) (5)
- Synthesis and Antitubercular Evaluation of Novel Dibenzo[b,d]furan and 9‐Methyl‐9H‐carbazole Derived Hexahydro‐2H‐pyrano[3,2‐c]quinolines via Povarov Reaction. (2012) (5)
- A stereo, regioselective synthesis and discovery of antimycobaterium tuberculosis activity of novel β-lactam grafted spirooxindolopyrrolidine hybrid heterocycles (2020) (5)
- Synthetic analogues of mycobacterial arabinogalactan linkage-disaccharide part II: synthesis and preliminary screening of lipophilic O-alkyl glycosides. (2011) (5)
- Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens. (2020) (5)
- Synthesis, antimycobacterial, antiviral, antimicrobial activities, and QSAR studies of isonicotinic acid-1-(substituted phenyl)-ethylidene/cycloheptylidene hydrazides (2011) (5)
- Novel antitubercular diallyl/dibenzylthiosemicarbazones endowed with high activity toward multi-drug-resistant tuberculosis (2012) (5)
- Synthesis and biological evaluation of novel N 1-decyl and C7- sec amine substituted fluoroquinolones as antitubercular and anticancer agents (2015) (5)
- Design, synthesis and screening studies of potent thiazol-2-amine derivatives as fibroblast growth factor receptor 1 inhibitors. (2014) (4)
- Some New Hydrazone Derivatives Bearing the 1,2,4-Triazole Moiety as Potential Antimycobacterial Agents (2018) (4)
- Synthesis and antimycobacterial activity of highly functionalized tetrahydro-4(1H)-pyridinones. (2011) (4)
- Design and characterisation of piperazine-benzofuran integrated dinitrobenzenesulfonamide as Mycobacterium tuberculosis H37Rv strain inhibitors (2021) (4)
- Syrltllesis and Alltituberculous activity of N-Mannich bases of 3-[4-(4 chloropheny1)-6-(4-methylphesyl) pyrimidin-2-yl] iminoisatin derivatives (2002) (4)
- Targeting HIV‐TB coinfection by developing novel piperidin‐4‐substituted imines: Design, synthesis, in vitro and in silico studies (2019) (4)
- Nevirapine derivatives with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. (2005) (4)
- Synthesis and pharmacological screening of some new derivatives of (Z)-[2-(2-substituted benzalamino-4-yl) hydrazono]-indolin-2-ones (2010) (4)
- Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents (2015) (4)
- Newer Tetracycline Derivatives: Synthesis, anti‐HIV, Antimycobacterial Activities and Inhibition of HIV‐1 Integrase. (2007) (4)
- A Microwave‐Assisted, Facile, Regioselective Friedlaender Synthesis and Antitubercular Evaluation of 2,9‐Diaryl‐2,3‐dihydrothieno[3,2‐b]quinolines. (2010) (4)
- Microwave Assisted Synthesis, AntiHIV, And AntiYFV Activities Of Schiff Bases Of N-HY-Droxy-N1-Aminoguanidine Tosylate (2005) (3)
- Inhibition of double stranded RNA dependent protein kinase (PKR) abrogates isoproterenol induced myocardial ischemia in vitro in cultured cardiomyocytes and in vivo in wistar rats. (2021) (3)
- Mycobacterial DNA gyrB inhibitors: Ligand based pharmacophore modelling and in vitro enzyme inhibition studies. (2014) (3)
- Heteroaryl-substuted semicarbazones: Synthesis and anticonvulsant activity of N-(3-methylpyridin-2-yl)-substituted semicarbazones (2006) (3)
- Synthesis and Biological Evaluation of Novel Benzhydrylpiperazine-Coupled Nitrobenzenesulfonamide Hybrids (2021) (3)
- Quantum mechanical modeling of N4-(2, 5-disubstituted phenyl) semicarbazones: synthesis and anticonvulsant activity of N4-(2, 5-dimethylphenyl/ -2-fluoro-5-methyl phenyl) semicarbazones. (2006) (3)
- Synthesis, antimycobacterial, antiviral, antimicrobial activities, and QSAR studies of nicotinic acid benzylidene hydrazide derivatives (2011) (3)
- One‐Pot Synthesis of New Triazole—Imidazo[2,1‐b][1,3,4]thiadiazole Hybrids via Click Chemistry and Evaluation of Their Antitubercular Activity. (2016) (3)
- Corrigendum to “Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus” [Bioorg. Med. Chem. 22 (2014) 5970–5987] (2015) (3)
- Synthesis of New Spirooxindole Derivatives Through 1,3‐Dipolar Cycloaddition of Azomethine Ylides and Their Antitubercular Activity. (2016) (3)
- Effect of Feature Selection on Kinase Classification Models (2015) (3)
- Discovery of Novel Antitubercular 2,10‐Dihydro‐4aH‐chromeno[3,2c]pyridin‐3‐yl Derivatives. (2010) (3)
- Bacterial FtsZ inhibition by benzo[d]imidazole-2-carboxamide derivative with anti-TB activity. (2022) (3)
- Novel piperazinyl derivatives with anti-hyperalgesic, anti-allodynic and anti-inflammatory activities useful for the treatment of Neuropathic Pain. (2012) (3)
- 3D-QSAR Studies Combined with Virtual Screening to Identify Novel Inhibitors of N-Acetyl Glucosamine 1-Phosphate Uridyltransferase from Mycobacterium Tuberculosis (2013) (2)
- Synthesis of Zidovudine Derivatives with anti-HIV-1 and Antibacterial Activities. (2009) (2)
- GABA derivatives for the treatment of epilepsy and neuropathic pain: A synthetic integration of GABA in 1, 2, 4–Triazolo–2H–one nucleus (2012) (2)
- Ameliorative effect of papain on behavioral and bio-chemical alterations in in-silico and In-vivo models of neuropathic pain in rats (2020) (2)
- First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights (2022) (2)
- Synthesis and Preliminary Screening of O-β-D-Galactopyranosides as Potential Mimic of UDP-Galp against Mycobacterium tuberculosis (2012) (2)
- Synthesis of 1 , 2 , 3-triazole incorporated monocarbonyl curcumin analogues as potent antitubercular , antifungal and antioxidant agents (2019) (2)
- S-alkylated thiosemicarbazone derivatives: Synthesis, crystal structure determination, antimicrobial activity evaluation and molecular docking studies (2021) (2)
- Design and development of novel inhibitors for the treatment of latent tuberculosis (2016) (2)
- Synthesis and anti-HIV activity of nevirapine prodrugs. (2006) (2)
- Combinatorial synthesis of anti-HIV agents--a review. (2005) (2)
- Facile Diversity‐Oriented Synthesis and Antitubercular Evaluation of Novel Aryl and Heteroaryl Tethered Pyridines and Dihydro‐6H‐quinolin‐5‐ones Derived via Variants of the Bohlmann—Rahtz Reaction. (2011) (2)
- Facile Three-Component Domino Reactions in the Regioselective Synthesis and Antimycobacterial Evaluation of Novel Indolizines and Pyrrolo[2,1-a]isoquinolines. (2011) (2)
- Novel Three-Component Domino Reactions of Ketones, Isatin and Amino Acids: Synthesis and Discovery of Antimycobacterial Activity of Highly Functionalized Novel Dispiropyrrolidines. (2010) (2)
- Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodology. (2022) (2)
- Anticancer Potential of N ‐Sulfonyl Noscapinoids: Synthesis and Evaluation (2020) (2)
- Novel fluoroquinolones containing 2‐arylamino‐2‐oxoethyl fragment: Design, synthesis, evaluation of antibacterial and antituberculosis activities and molecular modeling studies (2021) (2)
- Anti-mycobacterial activity of two natural Bisanthraquinones: (+)-1,1′-Bislunatin and (+)-2,2′-Epicytoskyrin A (2020) (2)
- Synthesis, antibacterial, antifungal and antitubercular activities of N-pyrazolylbenzamide derivatives. (2014) (2)
- Synthesis of novel 4,5‐dihydropyrrolo[1,2‐a]quinoxalines, pyrrolo[1,2‐a]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity (2020) (2)
- Discovery of Novel Inhibitors Targeting the Mycobacterium tuberculosis O‐Acetylserine Sulfhydrylase (CysK1) Using Virtual High‐Throughput Screening. (2013) (2)
- Synthesis and Antitubercular Evaluation of Amidoalkyl Dibenzofuranols and 1H‐Benzo[2,3]benzofuro[4,5‐e][1,3]oxazin‐3(2H)‐ones. (2011) (2)
- A nano-organo catalyst mediated approach towards the green synthesis of 3-methyl-4-(phenyl)methylene-isoxazole-5(4H)-one derivatives and biological evaluation of the derivatives as a potent anti-fungal and anti-tubercular agent (2023) (1)
- Structural Models for the Design of PKMzeta Inhibitors with Neurobiological Indications (2015) (1)
- Synthesis and Antituberculous Activity of N‐Mannich Bases of 3‐[4‐(4‐Chlorophenyl)‐6‐(4‐methylphenyl)pyrimidin‐2‐yl]iminoisatin Derivatives. (2002) (1)
- Synthesis and antimicrobial activity of 3-(4'-hydroxy-3'-methylphenyl)-5-[(substuted) phenyl]-4,5-dihydro-1H-1-pyrazolyl-4-pyridylmethanone derivatives. (2006) (1)
- Synthesis and in-vitro Antimycobacterial Evaluation of 1-(Cyclopropyl/2,4-difluorophenyl/tert-butyl) -1,4-dihydro-8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic Acids. (2009) (1)
- A Facile Domino Protocol for the Regioselective Synthesis and Discovery of Novel 2-Amino-5-arylthieno-[2,3-b]thiophenes as Antimycobacterial Agents. (2010) (1)
- L-Proline-Catalyzed Facile Green Protocol for the Synthesis and Antimycobacterial Evaluation of [1,4]-Thiazines. (2010) (1)
- Synthesis, Antitubercular and Anticancer Activities of Substituted Furyl‐quinazoli‐3(4H)‐ones. (2008) (1)
- Heteroaryl‐substituted Semicarbazones: Synthesis and Anticonvulsant Activity of N‐(3‐Methylpyridin‐2‐yl)‐substituted Semicarbazones. (2007) (1)
- Design and synthesis of new 3-((7-chloroquinolin-4-yl)amino)thiazolidin-4-one analogs as Mycobacterium tuberculosis DNA gyrase inhibitors (2021) (1)
- Aryl-n-hexanamide linked enaminones of usnic acid as promising antimicrobial agents. (2022) (1)
- Design, Synthesis, and in vitro biological evaluation of dehydroaripiprazole derivatives as antituberculosis agents and molecular docking study (2022) (1)
- Synthesis and In vitro Antibacterial, Antitubercular Studies of Novel Fluoroquinolones Analogs Containing 4-substituted Sec Amine (2020) (1)
- Editorial (Thematic Issue: Recent Trends in Library Design and Virtual Screening in Medicinal Chemistry and Drug Discovery) (2014) (1)
- Synthesis, Structure—Activity Relationship of Novel Substituted 4H‐Chromen‐1,2,3,4‐tetrahydropyrimidine‐5‐carboxylates as Potential Antimycobacterial and Anticancer Agents. (2011) (1)
- Ethyl Imidazole-1-Carboxylate as a Novel Carbonylating Agent for the Synthesis of 1,2,4-Oxadiazol-5(4H)-Ones and Evaluation of their Anti-Mycobacterial Activity (2017) (1)
- Indole‐2‐carboxamides as New Anti‐Mycobacterial Agents: Design, Synthesis, Biological Evaluation and Molecular Modeling against mmpL3 (2022) (1)
- Synthesis and anti-mycobacterial activity of 1H-1,2,3-triazolylisonicotinohydrazides (2016) (1)
- New tetrahydropyrimidine-1,2,3-triazole clubbed compounds: Antitubercular activity and Thymidine Monophosphate Kinase (TMPKmt) inhibition. (2022) (1)
- Synthetic Strategy, Characterization and Antimycobacterium Evaluation of 8-Hydroxy Quinoline Derivatives (2018) (1)
- EFFECTIVENESS OF ANTIEPILEPTIC GABA ANALOGUES FOR THE TREATMENT OF NEUROPATHIC PAIN (2010) (1)
- Microwave-Assisted Synthesis, And AntiHIV Activity Of 2,3-Dairyl-1,3-Thiazolidin-4-Ones (2005) (1)
- Isonicotinic acid hydrazide derivatives: synthesis, antimicrobial activity, and QSAR studies (2011) (0)
- Designing of small molecule inhibitors for NMPRTaseas Anticancer leads using insilico approach (2013) (0)
- A Green Expedient Synthesis of Pyridopyrimidine‐2‐thiones and Their Antitubercular Activity. (2011) (0)
- Erratum: First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights (2022) (0)
- A Facile Four‐Component Sequential Protocol in the Expedient Synthesis of Novel 2‐Aryl‐5‐methyl‐2,3‐dihydro‐1H‐3‐pyrazolones in Water and Their Antitubercular Evaluation. (2012) (0)
- Synthesis of Substituted Pyrazole Derivatives: Evaluation of their Anti- Mycobacterial Activity (2017) (0)
- Synthesis, biological evaluation and molecular docking study of some new 4-aminosalicylic acid derivatives as anti-inflammatory and antimycobacterial agents. (2023) (0)
- Editorial: Medicinal chemistry update and discovery strategies on potential therapeutic targets. (2014) (0)
- Regioselective Pd-Catalyzed Suzuki–Miyaura Borylation Reaction for the Dimerization Product of 6-Bromoimidazo[1,2- a ]pyridine-2-carboxylate: Mechanistic Pathway, Cytotoxic and Tubercular Studies (2022) (0)
- Layer-by-Layer Thin Films for Co-Delivery of TGF-β siRNA and Epidermal Growth Factor to Improve Excisional Wound Healing (2016) (0)
- Novel antitubercular diallyl/dibenzylthiosemicarbazones endowed with high activity toward multi-drug-resistant tuberculosis (2011) (0)
- 3D QSAR analysis of 2-(substituted aryl)-thiazolidine-4-carboxamides as potent antitubercular agents. (2015) (0)
- Advancing host-directed therapy for tuberculosis/MDR-TB: Development of novel AKT inhibitors as an adjunctive treatment for tuberculosis (2021) (0)
- CCDC 1051897: Experimental Crystal Structure Determination (2017) (0)
- Editorial: recent trends in library design and virtual screening in medicinal chemistry and drug discovery. (2014) (0)
- Synthesis of Disulfide‐Bridged N‐Phenyl‐N′‐(alkyl/aryl/heteroaryl)urea Derivatives and Evaluation of Their Antimicrobial Activities (2019) (0)
- Metal catalyst-free one-pot synthesis of carboxamide derivatives via Ugi-4CC reaction and its anti-tubercular study (2022) (0)
- Design and Identification of Mycobacterium tuberculosis Glutamate Racemase (MurI) Inhibitors (2017) (0)
- Svnthesis of Tetrahvdro-2 H-[ I . 3 . 5 lthiadiazine-544-pvridvlcarboxamido )-2-thione with antitubercular activitv (2017) (0)
- Synthesis and Antitubercular Activity of Fused Thieno-/Furo-quinoline Compounds. (2016) (0)
- Facile microwave-assisted synthesis and antitubercular evaluation of novel aziridine derivatives (2021) (0)
- Relationship Between Plasma Levels and the Anti-Neuropathic Pain Effect of Lamotrigine in Rats (2012) (0)
- Synthesis and antimycobacterial activities of some new N-acylhydrazone and thiosemicarbazide derivatives of 6-methyl-4,5-dihydropyridazin-3(2H)-one (2011) (0)
- A Solvent-Free, Four-Component Synthesis and 1,3-Dipolar Cycloaddition of 4(H)-Pyrans with Nitrile Oxides: Synthesis and Discovery of Antimycobacterial Activity of Enantiomerically Pure 1,2,4-Oxadiazoles. (2012) (0)
- Synthesis of novel 5-[(1,2,3-triazol-4-yl)methyl]-1-methyl-3H-pyridazino[4,5-b]indol-4-one derivatives by click reaction and exploration of their anticancer activity (2015) (0)
- Discovery of Molecules for the Treatment of Neuropathic Pain: Synthesis, Antiallodynic and Antihyperalgesic Activity of 5‐(4‐Nitrophenyl)furoic‐2‐acid Hydrazones. (2011) (0)
- Rational design, synthesis and evaluation of novel-substituted 1,2,3-triazolylmethyl carbazoles as potent inhibitors of Mycobacterium tuberculosis (2014) (0)
- Refinement of Existing Benzthiazole lead Targeting Lysine Aminotransferase in Dormant Stage of Mycobacterium tuberculosis (2017) (0)
- CCDC 1051896: Experimental Crystal Structure Determination (2017) (0)
- Novel Pyrimidine – Imines Against Tuberculosis: Rationale, In Vitro, In Silico Studies and Mechanistic Insights (2023) (0)
- Anthrylphosphonate and π-conjugated acid cocrystal as a Mycobacterium tuberculosis inhibitor: Role of P=O…H interactions (2021) (0)
- Effect of Physiochemical Properties on Classification Algorithms for Kinases Family (2016) (0)
- Isoflavonoid and Furanochromone Natural Products as Potential DNA Gyrase Inhibitors: Computational, Spectral, and Antimycobacterial Studies (2023) (0)
- Synthesis of novel 5-chloro-2-(thiophen-2-yl)-7,8-dihydroquinoline-6-carboxamides as potent inhibitors of Mycobacterium tuberculosis (2020) (0)
- Camphorsulfonic Acid Catalyzed Facile Tandem Double Friedlaender Annulation Protocol for the Synthesis of Phenoxy Linked Bisquinoline Derivatives and Discovery of Antitubercular Agents. (2012) (0)
- Anti-mycobacterial, cytotoxic activities of Knoevenagel and (E)-α,β-unsaturated esters and ketones from 2-chloronicotinaldehydes (2013) (0)
- Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug (2016) (0)
- Molecular Modelling Studies of Novel COX-2 Inhibitors (2019) (0)
- Antihypernociceptive effects of Petersianthus macrocarpus stem bark on neuropathic pain induced by chronic constriction injury in rats (2021) (0)
- Molecular Dynamics Studies on COX-2 Protein-tyrosine Analogue Complex and Ligand-based Computational Analysis of Halo-substituted Tyrosine Analogues (2019) (0)
- Synthesis and biological evaluation of novel N 1-decyl and C 7-sec amine substituted fluoroquinolones as antitubercular and anticancer agents (2015) (0)
- Unfortunately, in the article Synthesis of novel 4,5‐dihydropyrrolo[1,2‐a]quinoxalines, pyrrolo[1,2‐a]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity (2020) (0)
- Synthesis of 3-Isopropylbenzo[D]Oxazol-2(3H)-One Amides and UreaDerivatives; Evaluation of their Anti-Mycobacterial and Cytotoxic Activity (2017) (0)
- A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture (2015) (0)
- New fluoroquinolones/nitric oxide donor hybrids: design, synthesis and antitubercular activity (2019) (0)
- phene-1 , 2 , 3-triazoles with piperidine , piperazine , morpholine and thiomorpho-line appendages (2016) (0)
- Combinatorial Synthesis of anti‐HIV Agents (2006) (0)
- Special Issue on "Medicinal Chemistry" 2,4-Diaminotriazines as anti-infective agents (2020) (0)
- Design, Synthesis and Antitubercular Evaluation of Novel 2-Substituted-3H-benzofuro Benzofurans via Palladium—Copper Catalyzed Sonogashira Coupling Reaction. (2014) (0)
- Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation (2017) (0)
- Benzo[d]Thiazole-2-Carboxamides/Carbanilides as New Anti-TB Chemotypes Inhibiting the Mycobacterial ATP-Phosphoribosyl Transferase (HisG) (2022) (0)
- Benzo[d]thiazole-2-carboxamides as new antituberculosis chemotypes inhibiting mycobacterial ATP phosphoribosyl transferase. (2022) (0)
- Correction to Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents. (2020) (0)
- 1,3‐Dipolar Cycloaddition of C‐Aryl‐N‐phenylnitrones to (R)‐1‐(1‐Phenylethyl)‐3‐ [(E)‐arylmethylidene]tetrahydro‐4(1H)‐pyridinones: Synthesis and Antimycobacterial Evaluation of Enantiomerically Pure Spiroisoxazolidines. (2010) (0)
- Synthesis and Antimicrobial Activities of Some Novel Substituted 2‐Imidazolyl‐N‐(4‐oxo‐quinazolin‐3(4H)‐yl)‐acetamides. (2008) (0)
- Substituted Indolizines via a Multicomponent 1,3-DipolarCycloaddition Strategy (2011) (0)
- General and Efficient Synthesis of Benzoxazol-2(3H)-ones: Evolution of Their Anticancer and Antimycobacterial Activities. (2015) (0)
- Design and synthesis of novel 1, 4-thiazine derivatives as potent anti-tubercular agents (2011) (0)
- Synthesis and Bio‐evaluation of GR135486X Derivatives as Potent Anti‐Tubercular Agents (2023) (0)
- EXPLORIG ARYL THIAZOLIDIE CARBOXAMIDES AS AEW CLASS OF ATIMYCOBACTERIALS (2011) (0)
- Targeting host signalling AKT kinase pathway to overcome Mycobacterium tuberculosis infection (2018) (0)
- Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers (2015) (0)
- Antihypernociceptive effects of Petersianthus macrocarpus stem bark on neuropathic pain induced by chronic constriction injury in rats (2021) (0)
- The influence of Topoisomerase I (TopA) inhibitors on chromosome replication at single cell level in Mycobacterium smegmatis (2017) (0)
- Supplementary material from "Identification of potent chromone embedded [1,2,3]-triazoles as novel anti-tubercular agents" (2018) (0)
- Editorial (Thematic Issue: Medicinal Chemistry Updates and Discovery Strategies on Potential Therapeutic Targets) (2014) (0)
- Synthesis of Novel Dispiropyrrolothiazoles by Three-Component 1,3-Dipolar Cycloaddition and Evaluation of Their Antimycobacterial Activity. (2015) (0)
- Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function. (2023) (0)
- Ultrasound assisted synthesis of spirooxindole analogs catalyzed by Fe3O4@PPCA NPs: Experimental, theoretical and in vitro biological studies (2023) (0)
- 两种AZT-氟喹诺酮偶联物体外抗HIV-1及抗菌活性的研究 (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Dharmarajan Sriram?
Dharmarajan Sriram is affiliated with the following schools:
